A new three-dimensional model for emotions and monoamine neurotransmitters

Medical Hypotheses

Volumn 78, Issue 2, 2012, Pages 341-348

  Lövheim, Hugo ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MONOAMINE; MONOAMINE NEUROTRANSMITTER; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

ANGER; ARTICLE; BEHAVIOR; BRAIN STEM; DISTRESS SYNDROME; EMOTION; EXCITEMENT; FEAR; HAPPINESS; HUMAN; MODEL; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; RAGE; SHAME; THREE DIMENSIONAL IMAGING;

ALGORITHMS; AMINES; ANGER; ANIMALS; DOPAMINE; EMOTIONS; FEAR; HATE; HUMANS; MODELS, PSYCHOLOGICAL; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PLEASURE; PSYCHOTROPIC DRUGS; SEROTONIN; SHAME; STRESS, PSYCHOLOGICAL;

EID: 84855196400     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.11.016     Document Type: Article

References (187)

1. Purves D., Augustine G.J., Fitzpatrick D., Hall W.C., LaMantia A., McNamarra J.O., et al. Neuroscience 2004, Sinauer Associates, Sunderland.
2. Hannon J., Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008, 195:198-213.
3. Hornung J.P. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003, 26:331-343.
4. Benarroch E.E. The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology 2009, 73:1699-1704.
5. Heimer L. The human brain and spinal cord. Functional neuroanatomy and dissection guide 1995, Springer-Verlag, New York.
6. Girault J.A., Greengard P. The neurobiology of dopamine signaling. Arch Neurol 2004, 61:641-644.
7. Alenina N., Kikic D., Todiras M., Mosienko V., Qadri F., Plehm R., et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci USA 2009, 106:10332-10337.
8. Anstey M.L., Rogers S.M., Ott S.R., Burrows M., Simpson S.J. Serotonin mediates behavioral gregarization underlying swarm formation in desert locusts. Science 2009, 323:627-630.
9. Couppis M.H., Kennedy C.H. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology (Berl) 2008, 197:449-456.
10. Dennis R.L., Chen Z.Q., Cheng H.W. Serotonergic mediation of aggression in high and low aggressive chicken strains. Poult Sci 2008, 87:612-620.
11. Huber R., Smith K., Delago A., Isaksson K., Kravitz E.A. Serotonin and aggressive motivation in crustaceans: altering the decision to retreat. Proc Natl Acad Sci USA 1997, 94:5939-5942.
12. Kabelik D., Kelly A.M., Goodson J.L. Dopaminergic regulation of mate competition aggression and aromatase-Fos colocalization in vasotocin neurons. Neuropharmacology 2010, 58:117-125.
13. Kravitz E.A. Hormonal control of behavior: amines and the biasing of behavioral output in lobsters. Science 1988, 241:1775-1781.
14. Sawin E.R., Ranganathan R., Horvitz H.R. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 2000, 26:619-631.
15. Stahl S. Stahl's essential psychopharmacology. Neuroscientific basis and practical applications 2008, Cambridge University Press, Cambridge.
16. Keltikangas-Jarvinen L., Salo J. Dopamine and serotonin systems modify environmental effects on human behavior: a review. Scand J Psychol 2009, 50:574-582.
17. Lakatos K., Nemoda Z., Birkas E., Ronai Z., Kovacs E., Ney K., et al. Association of D4 dopamine receptor gene and serotonin transporter promoter polymorphisms with infants' response to novelty. Mol Psychiatry 2003, 8:90-97.
18. Szekely A., Ronai Z., Nemoda Z., Kolmann G., Gervai J., Sasvari-Szekely M. Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am J Med Genet B Neuropsychiatr Genet 2004, 126B:106-110.
19. Dolan M., Anderson I.M., Deakin J.F. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry 2001, 178:352-359.
20. Ebstein R.P., Benjamin J., Belmaker R.H. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 2000, 410:205-214.
21. Krause J., La Fougere C., Krause K.H., Ackenheil M., Dresel S.H. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci 2005, 255:428-431.
22. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., Fischman A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999, 354:2132-2133.
23. Gur R.E., Keshavan M.S., Lawrie S.M. Deconstructing psychosis with human brain imaging. Schizophr Bull 2007, 33:921-931.
24. Herrmann N., Lanctot K.L., Eryavec G., Khan L.R. Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients. J Psychopharmacol 2004, 18:215-220.
25. Hesse S., Ballaschke O., Barthel H., Sabri O. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder. Psychiatry Res 2009, 171:120-128.
26. Kalia M. Neurobiological basis of depression: an update. Metabolism 2005, 54:24-27.
27. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., et al. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 2003, 974:82-87.
28. Lanctot K.L., Herrmann N., Eryavec G., Van Reekum R., Reed K., Naranjo C.A. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology 2002, 27:646-654.
29. Marks D.M., Pae C.U., Patkar A.A. Triple reuptake inhibitors: the next generation of antidepressants. Curr Neuropharmacol 2008, 6:338-343.
30. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007, 12:331-359.
31. Sharp S.I., Ballard C.G., Ziabreva I., Piggott M.A., Perry R.H., Perry E.K., et al. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dement Geriatr Cogn Disord 2008, 26:330-338.
32. Meisenzahl E.M., Schmitt G.J., Scheuerecker J., Moller H.J. The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry 2007, 19:337-345.
33. Tanaka M., Yoshida M., Emoto H., Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 2000, 405:397-406.
34. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
35. Berntson G.G., Bechara A., Damasio H., Tranel D., Cacioppo J.T. Amygdala contribution to selective dimensions of emotion. Soc Cogn Affect Neurosci 2007, 2:123-129.
36. Pare D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
37. Klüver H., Bucy P. Psychic blindness and other symptoms following bilateral temporal lobectomy in Rhesus monkeys. Am J Physiol 1937, 119:352-353.
38. Adolphs R., Baron-Cohen S., Tranel D. Impaired recognition of social emotions following amygdala damage. J Cogn Neurosci 2002, 14:1264-1274.
39. Davidson R.J. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003, 40:655-665.
40. Terzian H., Ore G.D. Syndrome of Kluver and Bucy; reproduced in man by bilateral removal of the temporal lobes. Neurology 1955, 5:373-380.
41. LeDoux J. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
42. Talarovicova A., Krskova L., Kiss A. Some assessments of the amygdala role in suprahypothalamic neuroendocrine regulation: a minireview. Endocr Regul 2007, 41:155-162.
43. Phillips A.G., Ahn S., Howland J.G. Amygdalar control of the mesocorticolimbic dopamine system: parallel pathways to motivated behavior. Neurosci Biobehav Rev 2003, 27:543-554.
44. Sprengelmeyer R., Rausch M., Eysel U.T., Przuntek H. Neural structures associated with recognition of facial expressions of basic emotions. Proc Biol Sci 1998, 265:1927-1931.
45. De Martino B., Strange B.A., Dolan R.J. Noradrenergic neuromodulation of human attention for emotional and neutral stimuli. Psychopharmacology (Berl) 2008, 197:127-136.
46. Egerton A., Mehta M.A., Montgomery A.J., Lappin J.M., Howes O.D., Reeves S.J., et al. The dopaminergic basis of human behaviors: a review of molecular imaging studies. Neurosci Biobehav Rev 2009, 33:1109-1132.
47. Flugge G., Van Kampen M., Mijnster M.J. Perturbations in brain monoamine systems during stress. Cell Tissue Res 2004, 315:1-14.
48. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
49. Hikosaka O., Bromberg-Martin E., Hong S., Matsumoto M. New insights on the subcortical representation of reward. Curr Opin Neurobiol 2008, 18:203-208.
50. McGaughy J., Ross R.S., Eichenbaum H. Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 2008, 153:63-71.
51. Price J., Cole V., Goodwin G.M. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry 2009, 195:211-217.
52. Seo D., Patrick C.J., Kennealy P.J. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav 2008, 13:383-395.
53. Silva H., Iturra P., Solari A., Villarroel J., Jerez S., Vielma W., et al. Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder. Actas Esp Psiquiatr 2007, 35:387-392.
54. Tops M., Russo S., Boksem M.A., Tucker D.M. Serotonin: modulator of a drive to withdraw. Brain Cogn 2009, 71:427-436.
55. Landen M., Erlandsson H., Bengtsson F., Andersch B., Eriksson E. Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability. Neuropsychopharmacology 2009, 34:585-592.
56. Pearlstein T. Premenstrual dysphoric disorder: out of the appendix. Arch Womens Ment Health 2010, 13:21-23.
57. Bressan R.A., Crippa J.A. The role of dopamine in reward and pleasure behaviour-review of data from preclinical research. Acta Psychiatr Scand Suppl 2005, 14-21.
58. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 1999, 31:6-41.
59. Fields H.L., Hjelmstad G.O., Margolis E.B., Nicola S.M. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci 2007, 30:289-316.
60. Foote S.L., Aston-Jones G., Bloom F.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA 1980, 77:3033-3037.
61. Aston-Jones G., Rajkowski J., Kubiak P. Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task. Neuroscience 1997, 80:697-715.
62. Leggio G.M., Cathala A., Neny M., Rouge-Pont F., Drago F., Piazza P.V., et al. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. J Neurochem 2009, 111:614-623.
63. Jenner P., Sheehy M., Marsden C.D. Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease. Br J Clin Pharmacol 1983, 15(Suppl 2):277S-289S.
64. Millan M.J., Dekeyne A., Gobert A. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 1998, 37:953-955.
65. Mejias-Aponte C.A., Drouin C., Aston-Jones G. Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J Neurosci 2009, 29:3613-3626.
66. Fink K.B., Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 2007, 59:360-417.
67. Izard C. Human emotions 1977, Plenum Press, New York.
68. Izard C. Basic emotions, relations among emotions, and emotion-cognition relations. Psychol Rev 1992, 99:561-565.
69. Darwin C. The Expression of the emotions in man and animals 1890, Penguin Group 2009, London.
70. Ortony A., Turner T.J. What's basic about basic emotions?. Psychol Rev 1990, 97:315-331.
71. Posner J., Russell J.A., Peterson B.S. The circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathology. Dev Psychopathol 2005, 17:715-734.
72. Turner T.J., Ortony A. Basic emotions: can conflicting criteria converge?. Psychol Rev 1992, 99:566-571.
73. Schachter S., Singer J. Cognitive, social, and psychological determinants of emotional state. Psychol Rev 1962, 69:379-399.
74. Scherer K.R., Ellgring H. Are facial expressions of emotion produced by categorical affect programs or dynamically driven by appraisal?. Emotion 2007, 7:113-130.
75. Kemper T. How many emotions are there? Wedding the social and the autonomic components. Am J Sociol 1987, 93:263-289.
76. Ekman P. Are there basic emotions?. Psychol Rev 1992, 99:550-553.
77. Hennenlotter A., Schroeder U. Partly dissociable neural substrates for recognizing basic emotions: a critical review. Prog Brain Res 2006, 156:443-456.
78. Izard C. Innate and universal facial expressions: evidence from developmental and cross-cultural research. Psychol Bull 1994, 115:288-299.
79. Panksepp J. A critical role for " affective neuroscience" in resolving what is basic about basic emotions. In resolving what is basic about basic emotions. Psychol Rev 1992, 99:554-560.
80. Panksepp J. Affective consciousness: core emotional feelings in animals and humans. Conscious Cogn 2005, 14:30-80.
81. Tracy J.L., Robins R.W., Schriber R.A. Development of a FACS-verified set of basic and self-conscious emotion expressions. Emotion 2009, 9:554-559.
82. Plutchik R. The psychology and biology of emotion 1994, HarperCollins College Publishers, New York.
83. Nathanson D. Affect, sex, and the birth of the self, Norton & Company 1992, Norton & Company, New York.
84. Allport F. Social psychology 1924, The Riverside Press, Cambridge.
85. Tomkins S. Affect imagery consciousness volume I the positive affects 1962, Springer Publishing Company, New York.
86. Tomkins S. Affect imagery consciousness volume II the negative affects 1963, Springer Publishing Company, New York.
87. Tomkins S. Affect imagery consciousness volume III the negative affects anger and fear 1991, Springer Publishing Company, New York.
88. Panksepp J. Affective neuroscience. The foundations of human and animal emotions 1998, Oxford University Press, New York.
89. Tomkins S. The quest for primary motives: biography and autobiography of an idea. J Pers Soc Psychol 1981, 41:306-329.
90. Ekman P., Friesen W.V. Constants across cultures in the face and emotion. J Pers Soc Psychol 1971, 17:124-129.
91. Ekman P., Sorenson E.R., Friesen W.V. Pan-cultural elements in facial displays of emotion. Science 1969, 164:86-88.
92. Matsumoto D., Willingham B. Spontaneous facial expressions of emotion of congenitally and noncongenitally blind individuals. J Pers Soc Psychol 2009, 96:1-10.
93. Rainville P., Bechara A., Naqvi N., Damasio A.R. Basic emotions are associated with distinct patterns of cardiorespiratory activity. Int J Psychophysiol 2006, 61:5-18.
94. C.L. Stephens, I.C. Christie and B.H. Friedman, Autonomic specificity of basic emotions: Evidence from pattern classification and cluster analysis, Biol Psychol (2010).
95. K. Vytal and S. Hamann, Neuroimaging Support for Discrete Neural Correlates of Basic Emotions: A Voxel-based Meta-analysis, J Cogn Neurosci (2009).
96. Fusar-Poli P., Placentino A., Carletti F., Landi P., Allen P., Surguladze S., et al. Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci 2009, 34:418-432.
97. Collet C., Vernet-Maury E., Delhomme G., Dittmar A. Autonomic nervous system response patterns specificity to basic emotions. J Auton Nerv Syst 1997, 62:45-57.
98. Tomkins S. Affect theory. Emotions in the human face 1982, 355-395. Cambridge University Press, Cambridge. Second edition. P. Ekman, W. Friesen, P. Ellsworth (Eds.).
99. Tomkins S., McCarter R. What and where are the primary affects? Some evidence for a theory. Percept Mot Skills 1964, 18:119-158.
100. Ekman P., Friesen W.V., Simons R.C. Is the startle reaction an emotion?. J Pers Soc Psychol 1985, 49:1416-1426.
101. Fadok J.P., Dickerson T.M., Palmiter R.D. Dopamine is necessary for cue-dependent fear conditioning. J Neurosci 2009, 29:11089-11097.
102. Ponnusamy R., Nissim H.A., Barad M. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem 2005, 12:399-406.
103. de Oliveira A.R., Reimer A.E., Brandao M.L. Role of dopamine receptors in the ventral tegmental area in conditioned fear. Behav Brain Res 2009, 199:271-277.
104. Fadok J.P., Darvas M., Dickerson T.M., Palmiter R.D. Long-term memory for pavlovian fear conditioning requires dopamine in the nucleus accumbens and basolateral amygdala. PLoS One 2010, 5:e12751.
105. Lawrence A.D., Goerendt I.K., Brooks D.J. Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia 2007, 45:65-74.
106. Bowers D., Miller K., Mikos A., Kirsch-Darrow L., Springer U., Fernandez H., et al. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli. Brain 2006, 129:3356-3365.
107. Lawrence A.D., Calder A.J., McGowan S.W., Grasby P.M. Selective disruption of the recognition of facial expressions of anger. Neuroreport 2002, 13:881-884.
108. Dougherty D.D., Bonab A.A., Ottowitz W.E., Livni E., Alpert N.M., Rauch S.L., et al. Decreased striatal D1 binding as measured using PET and (11C)SCH 23, 390 in patients with major depression with anger attacks. Depress Anxiety 2006, 23:175-177.
109. Cannon D.M., Klaver J.M., Peck S.A., Rallis-Voak D., Erickson K., Drevets W.C. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and (11C)NNC-112. Neuropsychopharmacology 2009, 34:1277-1287.
110. Pasquini M., Picardi A., Biondi M., Gaetano P., Morosini P. Relevance of anger and irritability in outpatients with major depressive disorder. Psychopathology 2004, 37:155-160.
111. Painuly N., Sharan P., Mattoo S.K. Antecedents concomitants and consequences of anger attacks in depression. Psychiatry Res 2007, 153:39-45.
112. Rosenbaum J.F., Fava M., Pava J.A., McCarthy M.K., Steingard R.J., Bouffides E. Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment. Am J Psychiatry 1993, 150:1164-1168.
113. Fava M., Rosenbaum J.F., Pava J.A., McCarthy M.K., Steingard R.J., Bouffides E. Anger attacks in unipolar depression, Part 1: clinical correlates and response to fluoxetine treatment. Am J Psychiatry 1993, 150:1158-1163.
114. Barak Y., Plopski I., Tadger S., Paleacu D. Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study. Int Psychogeriatr 2011, 1-5.
115. Luby J., Belden A., Sullivan J., Hayen R., McCadney A., Spitznagel E. Shame and guilt in preschool depression: evidence for elevations in self-conscious emotions in depression as early as age 3. J Child Psychol Psychiatry 2009, 50:1156-1166.
116. Orth U., Berking M., Burkhardt S. Self-conscious emotions and depression: rumination explains why shame but not guilt is maladaptive. Pers Soc Psychol Bull 2006, 32:1608-1619.
117. Vikan A., Hassel A.M., Rugset A., Johansen H.E., Moen T. A test of shame in outpatients with emotional disorder. Nord J Psychiatry 2010, 64:196-202.
118. Pollack M.H. Comorbid anxiety and depression. J Clin Psychiatry 2005, 66(Suppl 8):22-29.
119. Schneier F.R. Clinical practice. Social anxiety disorder. N Engl J Med 2006, 355:1029-1036.
120. Maron E., Kuikka J.T., Ulst K., Tiihonen J., Vasar V., Shlik J. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci 2004, 254:392-396.
121. van der Wee N.J., van Veen J.F., Stevens H., van Vliet I.M., van Rijk P.P., Westenberg H.G. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med 2008, 49:757-763.
122. Tangney J.P., Wagner P., Gramzow R. Proneness to shame, proneness to guilt, and psychopathology. J Abnorm Psychol 1992, 101:469-478.
123. Fergus T.A., Valentiner D.P., McGrath P.B., Jencius S. Shame- and guilt-proneness: relationships with anxiety disorder symptoms in a clinical sample. J Anxiety Disord 2010, 24:811-815.
124. Walsh K., Bennett G. Parkinson's disease and anxiety. Postgrad Med J 2001, 77:89-93.
125. Dissanayaka N.N., Sellbach A., Matheson S., O'Sullivan J.D., Silburn P.A., Byrne G.J., et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010, 25:838-845.
126. Hettema J.M., An S.S., Bukszar J., Van den Oord E.J., Neale M.C., Kendler K.S., et al. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 2008, 64:302-310.
127. McGrath M., Kawachi I., Ascherio A., Colditz G.A., Hunter D.J., De Vivo I. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 2004, 161:1703-1705.
128. Scahill L., Leckman J.F., Schultz R.T., Katsovich L., Peterson B.S. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130-1135.
129. Emmanuel N.P., Brawman-Mintzer O., Morton W.A., Book S.W., Johnson M.R., Lorberbaum J.P., et al. Bupropion-SR in treatment of social phobia. Depress Anxiety 2000, 12:111-113.
130. Schank J.R., Liles L.C., Weinshenker D. Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. Biol Psychiatry 2008, 63:1007-1012.
131. Nutt D.J., Bell C.J., Malizia A.L. Brain mechanisms of social anxiety disorder. J Clin Psychiatry 1998, 59(Suppl 17):4-11.
132. Yu B.H., Kang E.H., Ziegler M.G., Mills P.J., Dimsdale J.E. Mood states, sympathetic activity, and in vivo beta-adrenergic receptor function in a normal population. Depress Anxiety 2008, 25:559-564.
133. Ross S., Peselow E. The neurobiology of addictive disorders. Clin Neuropharmacol 2009, 32:269-276.
134. A.C. Galvao, R.C. Kruger, P.D. Campagnolo, V.S. Mattevi, M.R. Vitolo and S. Almeida, Association of MAOA and COMT gene polymorphisms with palatable food intake in children, J Nutr Biochem (2011).
135. Faure A., Reynolds S.M., Richard J.M., Berridge K.C. Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens. J Neurosci 2008, 28:7184-7192.
136. Berridge K.C. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996, 20:1-25.
137. Mallo T., Alttoa A., Koiv K., Tonissaar M., Eller M., Harro J. Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression and extracellular levels of dopamine. Behav Brain Res 2007, 177:269-281.
138. Ortigue S., Bianchi-Demicheli F., Patel N., Frum C., Lewis J.W. Neuroimaging of love: fMRI meta-analysis evidence toward new perspectives in sexual medicine. J Sex Med 2010, 7:3541-3552.
139. Tancer M., Johanson C.E. The effects of fluoxetine on the subjective and physiological effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 2007, 189:565-573.
140. Nichols D.E. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 1986, 18:305-313.
141. Cami J., Farre M., Mas M., Roset P.N., Poudevida S., Mas A., et al. Human pharmacology of 3, 4-methylenedioxymethamphetamine (" ecstasy" ): psychomotor performance and subjective effects. J Clin Psychopharmacol 2000, 20:455-466.
142. Curran H.V., Rees H., Hoare T., Hoshi R., Bond A. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology (Berl) 2004, 173:425-433.
143. Bedi G., Hyman D. H. de Wit, Is ecstasy an " empathogen" ? Effects of +/-3, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 2010, 68:1134-1140.
144. Parrott A.C. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 2001, 16:557-577.
145. Orosco M., Rouch C., Beslot F., Feurte S., Regnault A., Dauge V. Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behav Brain Res 2004, 148:1-10.
146. Murphy S.E., Longhitano C., Ayres R.E., Cowen P.J., Harmer C.J. Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology (Berl) 2006, 187:121-130.
147. Kemp A.H., Gray M.A., Silberstein R.B., Armstrong S.M., Nathan P.J. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage 2004, 22:1084-1096.
148. Norbury R., Taylor M.J., Selvaraj S., Murphy S.E., Harmer C.J., Cowen P.J. Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology (Berl) 2009, 206:197-204.
149. Tondo L., Vazquez G., Baldessarini R.J. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 2010, 121:404-414.
150. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC (2000).
151. Corona G., Ricca V., Bandini E., Mannucci E., Lotti F., Boddi V., et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med 2009, 6:1259-1269.
152. Opbroek A., Delgado P.L., Laukes C., McGahuey C., Katsanis J., Moreno F.A., et al. Emotional blunting associated with SSRI-induced sexual dysfunction Do SSRIs inhibit emotional responses?. Int J Neuropsychopharmacol 2002, 5:147-151.
153. Young E.J., Williams C.L. Valence dependent asymmetric release of norepinephrine in the basolateral amygdala. Behav Neurosci 2010, 124:633-644.
154. Rodriguez-Manzo G., Fernandez-Guasti A. Participation of the central noradrenergic system in the reestablishment of copulatory behavior of sexually exhausted rats by yohimbine, naloxone, and 8-OH-DPAT. Brain Res Bull 1995, 38:399-404.
155. Ventura R., Latagliata E.C., Morrone C., La Mela I. Prefrontal norepinephrine determines attribution of " high" motivational salience. PLoS One 2008, 3:e3044.
156. Hoebel B.G., Hernandez L., Schwartz D.H., Mark G.P., Hunter G.A. Microdialysis studies of brain norepinephrine Serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann N Y Acad Sci 1989, 575:171-191. discussion 192-173.
157. Hagemann L.F., Costa C.V., Zeni L.Z., Freitas C.G., Marino-Neto J., Paschoalini M.A. Food intake after adrenaline and noradrenaline injections into the hypothalamic paraventricular nucleus in pigeons. Physiol Behav 1998, 64:645-652.
158. Wellman P.J. Norepinephrine and the control of food intake. Nutrition 2000, 16:837-842.
159. Dutton D.G., Aron A.P. Some evidence for heightened sexual attraction under conditions of high anxiety. J Pers Soc Psychol 1974, 30:510-517.
160. Aan Het Rot M., Coupland N., Boivin D.B., Benkelfat C., Young S.N. Recognizing emotions in faces: effects of acute tryptophan depletion and bright light. J Psychopharmacol 2010, 24:1447-1454.
161. Douglas K.M., Porter R.J. Recognition of disgusted facial expressions in severe depression. Br J Psychiatry 2010, 197:156-157.
162. Montagne B., Schutters S., Westenberg H.G., Van Honk J., Kessels R.P., De Haan E.H. Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder. Cogn Neuropsychiatry 2006, 11:389-401.
163. Mosher T.M., Smith J.G., Greenshaw A.J. Aversive stimulus properties of the 5-HT2C receptor agonist WAY 161503 in rats. Neuropharmacology 2006, 51:641-650.
164. Zarzana E.C., Basso A.S., Costa-Pinto F.A., Palermo-Neto J. Pharmacological manipulation of immune-induced food aversion in rats. Neuroimmunomodulation 2009, 16:19-27.
165. Patanwala A.E., Amini R., Hays D.P., Rosen P. Antiemetic therapy for nausea and vomiting in the emergency department. J Emerg Med 2010, 39:330-336.
166. Kang J.I., Kim S.J., Namkoong K., An S.K. Association of DRD4 and COMT polymorphisms with disgust sensitivity in healthy volunteers. Neuropsychobiology 2010, 61:105-112.
167. Ille R., Schony M., Kapfhammer H.P., Schienle A. Elevated disgust proneness in schizophrenia. J Clin Psychol 2010, 66:1090-1100.
168. Suslow T., Roestel C., Ohrmann P., Arolt V. The experience of basic emotions in schizophrenia with and without affective negative symptoms. Compr Psychiatry 2003, 44:303-310.
169. Mark G.P., Blander D.S., Hoebel B.G. A conditioned stimulus decreases extracellular dopamine in the nucleus accumbens after the development of a learned taste aversion. Brain Res 1991, 551:308-310.
170. Mas M., Fumero B., González-Mora J.L. Voltammetric and microdialysis monitoring of brain monoamine neurotransmitter release during sociosexual interactions. Behav Brain Res 1995, 71:69-79.
171. Russell J. A Circumplex Model of Affect. J Pers Soc Psychol 1980, 39:1161-1178.
172. Izard C., Nunnally J. Evaluative responses to affectively positive and negative facial photographs: factor structure and construct validity. Educ Psychol Meas 1965, 25:1061-1071.
173. Frijda N.H., Philipszoon E. Dimensions of recognition of expression. J Abnorm Soc Psychol 1963, 66:45-51.
174. Russell J. Pancultural aspects of the human conceptual organization of emotions. J Pers Soc Psychol 1983, 45:1281-1288.
175. Schlosberg H. A scale for the judgment of facial expressions. J Exp Psychol 1941, 29:497-510.
176. Schlosberg H. The description of facial expressions in terms of two dimensions. J Exp Psychol 1952, 44:229-237.
177. Abelson R.P., Sermat V. Multidimensional scaling of facial expressions. J Exp Psychol 1962, 63:546-554.
178. Block J. Studies in the phenomenology of emotions. J Abnorm Psychol 1957, 54:358-363.
179. Bush L.E. Individual differences multidemensional scaling of adjectives denoting feelings. J Pers Soc Psychol 1973, 25:50-57.
180. Osgood C. Dimensionality of the semantic space for communication via facial expressions. Scand J Psychol 1966, 7:1-30.
181. Thompson D.F., Meltzer L. Communication of emotional intent by facial expression. J Abnorm Psychol 1964, 68:129-135.
182. Triandis H.C., Lambert W.W. A restatement and test of Schlosberg's theory of emotion with two kinds of subjects from Greece. J Abnorm Psychol 1958, 56:321-328.
183. Osgood C. Studies on the generality of affective meaning systems. Am Psychol 1962, 17:10-28.
184. Russell J. Evidence for a three-factor theory of emotions. J Res Pers 1977, 11:273-294.
185. W.M. Wundt, Outlines of Psychology. In: Classics in the history of psychology. , York University 2010, Toronto (1897). http://psychclassics.asu.edu/index.htm.
186. Watson D., Wiese D., Vaidya J., Tellegen A. The two general activation systems of affect: structural findings. Evolutionary considerations, and psychobiological evidence. J Pers Soc Psychol 1999, 76:820-838.
187. Schlosberg H. Three dimensions of emotion. Psychol Rev 1954, 61:81-88.